Clinical Trial Update: Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (EQUIP) is evaluating estrogen therapy to improve quality of life for men with newly diagnosed or recurrent metastatic hormone-sensitiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-sensitive Prostate Cancer
• Stage Ivb Prostate Cancer

Drugs mentioned

• Estrogen therapy (estradiol)

Snippet

Sponsor: University of Washington | Conditions: Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING